The House passed its version of a “right-to-try” bill on Wednesday, but it gained little notice because it was overshadowed by the omnibus spending bill that had just become public and which President Trump signed on Friday.

The right-to-try legislation, if signed into law, will allow terminally ill patients to seek drug treatments that have passed phase one of the FDA’s approval process, but have not yet received full approval.